As a benefits leader, you can improve ROI and support cancer prevention and early detection by:
1) Helping your employees get access to trusted resources with the latest information on precision medicine, as it relates to their health history and risk profile, in advance of full adoption, mitigating some of the risks Dr. Blobe outlined.
2) Focusing on implementing solutions that enhance healthcare literacy in the workplace. Even if you decide not to adopt a global policy on precision medicine for prevention, participants will eventually face these options with their primary care doctors or specialists. The BGH has a good roadmap that illustrates the possible gaps on the journey.
3) Continue to double-down on the actions your employees can take at this time to prevent cancer and boost health — tobacco cessation, regular exercise, proper sun protection, alcohol reduction, and getting recommended screenings based on age and risk; these are the things that drive wellness and have a substantial positive impact on employees.
4) Finally, invest time in understanding how precision medicine is addressed in your health plan and benefits strategy today. At least a quarter of employers surveyed by BGH didn’t know what tests were actually covered, presenting an opportunity to be on the front foot in promoting quality and more personalized care as innovations occur.
As always, if you would like to share your experiences with me or have further questions, please email me at: bipin.mistry@alight.com.